Present study demonstrated that fibrillar β-amyloid peptide (fAβ 1-42 ) induced ATP release, which in turn activated NADPH oxidase via the P2X 7 receptor (P2X 7 R). Reactive oxygen species (ROS) production in fAβ1-42-treated microglia appeared to require Ca 2+ influx from extracellular sources, because ROS generation was abolished to control levels in the absence of extracellular Ca
Introduction
A neuropathological characteristic of Alzheimer's disease (AD) is the appearance of neuritic plaques consisting of extracellular beta-amyloid peptide (Aβ) surrounded by reactive microglial cells (Sastre et al., 2006) . It has been suggested that fibrillar Aβ (fAβ) stimulates reactive oxygen species (ROS) production from cultured microglial cells via activation of NADPH oxidase (Bianca et al., 1999) . In addition, fAβ mediated neurotoxicity in mixed neuron-microglia cultures by causing the production of ROS (Qin et al., 2002) . Furthermore, NADPH oxidase activation has been identified in AD brains (Shimohama et al., 2000) . These findings suggest that microglia-mediated oxidative stress, via NADPH oxidase activation, plays a critical role in the pathogenesis of AD.
NADPH oxidase is a multicomponent enzyme that is composed of the cytosolic components, p40 phox , p47 phox , p67 phox and the small G-protein Rac, and the plasma membrane components p22 phox and gp91 phox (Lambeth, 2004) . Activation of NADPH oxidase occurs when inflammatory stimuli bring about the phosphorylation of p47 phox and p67 phox , and GDP/GTP exchange on Rac, causing these proteins to translocate to the membrane, where they assemble with p22 phox and gp91 phox (DeLeo and Quinn, 1996) . The translocation of both the p47 phox and p67 phox subunits from the cytosol to the membrane has been observed in AD brain and fAβ-stimulated microglial cells (Bianca et al., 1999; Shimohama et al., 2000) . However, the mechanisms responsible for this fAβ-stimulated NADPH oxidase activation remain largely unknown.
ATP is known to be released by neurons and glia under conditions such as trauma, ischemia/ hypoxia, and inflammation, and such release is a potential cause of neurodegeneration (Burnstock, 2007) . Extracellular ATP has been reported to stimulate ROS production via P2 purinergic receptors in eosinophils and microglia (Dichmann et al., 2000; Parvathenani et al., 2003) . In eosinophils, elevation of intracellular calcium concentra-tion ([Ca 2+ ] i ) plays a crucial role in the regulation of ROS production (Dichmann et al., 2000) . In microglia [Ca 2+ ] i increases caused by the stimulation of the P2X 7 receptor (P2X 7 R) induces NADPH oxidase-mediated superoxide generation (Parvathenani et al., 2003) . More importantly, upregulated expression of P2X7R in AD brain and fAβ-treated microglial cells has been recently reported (McLarnon et al., 2006) .
Taking these data together, we hypothesized that ROS production in fAβ-stimulated microglia might be mediated by ATP released from the microglia. To explore this hypothesis further, we determined whether fAβ-stimulated microglia release ATP, which could then modulate [Ca 2+ ] i elevation via P2X 7 R, resulting in ROS production.
Materials and Methods

Reagents
An Aβ peptide corresponding to human Aβ amino acids 1-42 (Aβ 1-42 ) was purchased from the American Peptide Company (Sunnyvale, CA). Pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS), adenosine 5'-triphosphate 2', 3'-acylic dialcohol (oxidized ATP; oATP), apyrase (an ATP-hydrolyzing enzyme), 2',7'-dihydrodichlorofluorescein diacetate (DCF-DA), pluronic F-127, DNase I, an ATP bioluminescence assay kit, and a protease inhibitor mixture, were all purchased from Sigma (St. Louis, MO). The Amplex Red hydrogen peroxide/peroxidase assay kit and the Ca 2+ indicator Fluo-3/AM were from Molecular Probes (Eugene, OR).
Microglial cell culture
Microglial cultures were prepared from the brains of 3-day-old Sprague-Dawley rats as described previously (Kim et al., 2002) . Briefly, whole brains were dissected into small cubes, incubated in D-PBS (JBI, Taegu, Korea) containing 0.1% trypsin and 40 µg/ml DNase I for 15 min at 37 o C, and dissociated into single cells by gentle pipetting. Dissociated cells were suspended in DMEM (JBI) containing 5% horse serum, 5 mg/ml glucose, 100 U/ml penicillin and 100 µg/ml streptomycin, and plated on poly-D-lysine-coated T-75 culture flasks, and incubated at 37 o C in incubator with 5% CO2/ 95% air atmosphere. After 2-4 weeks of growth in flasks, microglia floating in the medium were collected and grown in separate 96-well plates or on coverslips.
Detection of ROS
(1) Measurement of extracellular ROS: Microglial cells were plated at approximately 1 ×10 5 cells/well in 96-well plates, and then stimulated with fAβ1-42. For preparing fAβ, the lyophilized Aβ1-42 peptides were dissolved in sterile 10% DMSO in PBS at a concentration of 350 µM and aged 5-7 d at 37 o C, and then diluted in a culture medium for use in the experiments. After fAβ1-42 treatment, 100 µl of supernatant were transferred to microplate and mixed with 100 µl DMEM without phenol red but containing of 0.5 µM Amplex Red, and 1 U/ml HRP (Amplex Red hydrogen peroxide/peroxidase assay kit). The Amplex Red reagent reacts with H2O2 in the presence of HRP to produce the fluorescent compound resorufin (Zhou et al., 1997) . Fluorescence intensities were measured at indicated times using a LS-55 luminescence spectrophotometer (Perkin Elmer Instruments, Wellesley, MA).
(2) Measurement of intracellular ROS: Intracellular ROS levels were measured using the fluorescent dye DCF-DA, which is readily converted to a fluorescent product in the presence of ROS in cells. In brief, cells were preincubated with PPADS (10, 100 µM), oATP (10, 100 µM), 500 µM EGTA, or 5 U of apyrase, and then treated with 0.5 µM fAβ1-42. fAβ1-42-stimulated cells were incubated with 10 µM DCF-DA in HBSS (145 mM NaCl, 2.5 mM KCl, 1.8 mM MgCl2, 1 mM CaCl2, 10 mM Dglucose and 20 mM HEPES; pH 7.4) for 30 min. The cells were then washed extensively with D-PBS to remove extracellular DCF-DA, and fluorescence images were taken using an IX71 confocal laser scanning microscope (Olympus; Tokyo, Japan).
Ca
2+ imaging
Intracellular Ca 2+ concentration was monitored by loading cells with the fluorescent Ca 2+ indicator Fluo-3/AM, convertible to Fluo-3 in the presence of Ca 2+ . Cultured microglia plated onto poly-D-lysinecoated 25 mm glass coverslips were incubated with 2 µM of the acetoxymethyl ester of Fluo-3 (Fluo-3/AM) and 0.02% pluronic F-127 in HBSS for 30 min at 37 o C, and then washed with HBSS. Fluo-3-loaded cells were placed in a perfusion chamber mounted on the stage of a confocal laser-scanning microscope and stimulated with 0.5 µM fAβ1-42. To measure the intracellular calcium concentration, a confocal laser-scanning microscope (IX71, Olympus) equipped with an Argon/ Keron laser (15 mW; Coherent, Santa Clara, CA) was used. Fluo-3 was excited by the 488 nm line of an argon laser and the fluorescence was measured at an emission wavelength above 510 nm. (A) H2O2 production in microglia stimulated with various concentrations of fAβ1-42 was determined over 6 h. The amounts of H2O2 released into media were measured using Amplex Red. (B) Intracellular ROS levels were assayed using 10 µM DCF as described in Materials and Methods. Fluorescence (DCF) images were taken using an IX71 confocal microscope (Olympus). Scale bar, 100 µm.
Western blot analysis
Microglial cells treated with fAβ1-42 were lysed with lysis buffer (10 mM Na2HPO4, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, and 1% NP 40; pH 7.5). Lysates were centrifuged at 13,000 × g for 10 min at 4 o C and supernatants were collected. An aliquot of each sample containing 20 µg total protein was loaded onto a 10% acrylamide gel, and then transferred to a PVDF membrane. The blots were incubated with blocking buffer [0.5% skim milk in TBST (20 mM Tris-HCl, 500 mM NaCl, 0.05% Tween 20, pH 7.5)] at room temperature for 1 h, and incubated with primary monoclonal antibodies against the p67 phox (1:500; BD Biosciences, San Diego, CA), and HRP conjugated anti-mouse secondary antibody (1:1,000; Amersham Pharmacia).
Cell fractionation
Microglial cells were harvested and resuspended in a cold hypotonic solution (0.25 M sucrose, 10 mM Tris-HCl, and 5 mM MgCl 2 ; pH 7.4) including a protease inhibitor mixture, and centrifuged at 600 × g for 10 min. The supernatant was ultracentrifuged at 100,000 × g for 1.5 h at 4 o C. The resulting supernatant was removed and saved as the cytosolic fraction, and the membrane pellet was resuspended in hypotonic solution containing 1% Triton X-100. Samples were analyzed by Western blotting using antibodies against the NADPH oxidase components, as described above.
ATP efflux measurement
To examine whether extracellular ATP was released from microglial cells by fAβ 1-42 treatment, cells (3 × 10 4 cells/well) were plated in 96-well plates, and treated with 0.5 µM fAβ 1-42 for various times. After incubation, supernatant fluids of individual wells were transferred into sterile tubes and heated at 95 o C for 2 min. Extracellular ATP in supernatants was immediately measured using the luciferase-luciferin assay of the ATP bioluminescence assay kit following the instructions of the manufacturer using a luminometer (TD2020; Turner Designs, Sunnyvale, CA).
Statistical analysis
All statistical comparisons in this study were performed using one-way ANOVA with the TukeyKramer multiple comparisons test, and data are expressed as mean ± SEM. A value of P ＜ 0.05 was considered statistically significant. Figure 1A shows that minimum concentration of containing 0.5 mM EGTA, and then stimulated with 0.5 µM fAβ1-42. (A) Intracellular Ca 2+ concentration was measured by Fluo-3 as described in Materials and Methods, and represented by the ratio between the fluorescence intensity after treatment (F) and fluorescence in the resting state (F0). (B) Intracellular ROS levels were assayed using 10 µM DCF. Fluorescence (DCF) images were taken using an IX71 confocal microscope (Olympus). Scale bar, 100 µm. fAβ1-42 required for ROS production in microglia is 0.5 µM. Release of H2O2 commenced at 1 h, peaked at 2 h after fAβ1-42 treatment, and then continued for 6 h. Next, we evaluated intracellular ROS levels in microglia stimulated with 0.5 µM fAβ1-42 by measuring fluorescence signals from DCF-DA. The DCF fluorescence signals also significantly increased in the interval 0.5-6 h after fAβ1-42 treatment ( Figure 1B) . These results indicate that ROS production in fAβ1-42-stimulated microglia is initiated slowly, and continues for a long period.
Results
fAβ1-42 induces sustained ROS production in microglia
Extracellular Ca 2+ is required for fAβ 1-42 -induced ROS production in microglia
Previous studies showed that ROS production in phagocytic cells is mediated by [Ca 2+ ]i elevation Geiszt et al., 1999 (Figure 2A) . The DCF fluorescence signals showed that fAβ1-42-stimulated ROS production was blocked to control levels when cells were preincubated in EGTA-containing Ca 2+ -free medium ( Figure 2B ). These results clearly suggest that Ca 2+ influx from the extracellular milieu is necessary for the fAβ1-42-induced ROS production. fAβ 1-42 -induced Ca 2+ influx and ROS production are mediated by ATP released from microglia through P2X 7 R activation Superoxide generation by Ca 2+ influx through P2X7R was observed in microglia (Parvathenani et al., 2003) . Therefore, we examined whether fAβ 1-42 -induced Ca 2+ influx was mediated through P2X7R activation. Apyrase treatment prevented fAβ 1-42 -induced Ca 2+ influx in a dose dependent manner ( Figure 3A ), indicating that fAβ 1-42 -induced Ca influx is mediated by ATP released from microglia. Pretreatment of microglia with the P2X7R antagonists PPADS (100 µM) or oATP (100 µM) inhibited fAβ 1-42 -induced Ca 2+ influx to baseline levels ( Figure 3B ). Next, we measured DCF fluorescence signals in microglial cells pretreated with PPADS or oATP. As can be seen in Figure 3C and D, DCF fluorescence signals were significantly suppressed by PPADS and oATP at 10-100 µM. These results suggest that the fAβ 1-42 -induced Ca 2+ influx is mediated primarily through the activation of the P2X7R, resulting in ROS generation.
fAβ1-42-induced NADPH oxidase activation is mediated by ATP released from microglia
We examined the activation of NADPH oxidase by monitoring the membrane translocation of p67 phox over time. Following fAβ1-42 treatment, the amounts of p67 phox in the membrane fraction increased up to 90 min post-treatment, and then decreased over the next 6 h ( Figure 4A ). In addition, PPADS, oATP, EGTA, and apyrase (an ATP-hydrolyzing enzyme) prevented the fAβ1-42-induced membrane translocation of p67 phox ( Figure 4B ). Translocation of the cytosolic factor p67 phox to the plasma membrane started at about 30 min post-stimulation, and was prevented by apyrase treatment. Based on these findings, we wondered whether ATP is released from fAβ1-42-stimulated microglia. The ROS production was abolished by apyrase treatment, but was not affected by boiled apyrase (Figure 4C and D), suggesting that ATP released from Aβ1-42-stimulated microglia might trigger ROS production. We also found that the amount of extracellular ATP reached a maximum level 1 h after stimulation with fAβ1-42, and this level was sustained for 6 h ( Figure  4E ). These results suggest that fAβ1-42-induced P2X 7 R activation may be regulated by ATP released from microglia in an autocrine manner.
Discussion
The major new finding in this study is that fAβ 1-42 induces ATP release from microglia and that ATP regulates ROS generation through the activation of P2X7R and Ca 2+ influx. It is believed that phagocytes including neutrophils and macrophages produce ROS to counter invading pathogens, in a phenomenon known as the respiratory burst. An excess of the superoxide anion (O 2 ) can, however, cause serious damage to the host. The phagocyte NADPH oxidase is a major enzyme catalyzing the non-mitochondrial production of O2 (Lambeth, 2004) . The activation of NADPH oxidase must therefore be tightly controlled. For example, the bacterial chemoattractant fMet-Leu-Phe (fMLF)-mediated O2 production in human polymorphonuclear leukocytes peaked at 45 s, and then declined rapidly to 50% of maximal by 2 min (McPhail and Snyderman, 1983) . In contrast, ROS production in our experiments was initiated slowly and continued for a long period. This implied that fAβ1-42-stimulated ROS production in microglia employed a process different from the mechanisms used for transient ROS generation in phagocytic cells.
The best-characterized signaling pathway for ROS production in neutrophils is NADPH oxidase activation resulting from elevation in [Ca 2+ ] i through a process termed store-operated Ca 2+ influx (Thelen et al., 1993) . The fMLF-induced activation of the G-protein-coupled formyl peptide receptor triggers Ca 2+ release from intracellular stores, followed by an influx of Ca 2+ through the plasma membrane (Granfeldt et al., 2002) . In contrast, our experiments showed that fAβ1-42 stimulation provoked Ca 2+ influx but not Ca 2+ release from intracellular stores, and that ROS production was decreased to control levels by blocking Ca 2+ influx. These differences in methods of [Ca 2+ ] i increase may be correlated with the sustained production of ROS in our experiment compared with transient ROS generation in phagocytic cells. In fact, a recent study showed that BzATP, a P2X 7 R-specific agonist, caused Ca 2+ influx from extracellular sources only (Parvathenani et al., 2003) . We therefore examined the possible involvement of P2X 7 R in fAβ1-42-mediated [Ca 2+ ]i changes and ROS generation, and found that fAβ1-42-induced ROS generation in microglia was entirely attributable to the activation of P2X 7 R. A recent study also reported that P2X 7 R expression was upregulated in primary microglia obtained from an AD brain, and that ATP abnormally triggered the Ca 2+ response (McLarnon et al., 2005) .
A putative mechanism explaining P2X 7 Rdependent ROS generation in fAβ1-42-stimulated microglia is that fAβ1-42 stimulates the secretion of ATP from microglial cells, and that the released ATP subsequently stimulates P2X 7 R activity. In support of this hypothesis, our results showed that both the translocation of p67 phox and ROS production were prevented by EGTA, PPADS, oATP, or apyrase treatment. Furthermore, ATP release from fAβ1-42-stimulated microglia was confirmed. Notably, the time course of ATP release agreed with the kinetics of p67 phox translocation and ROS production, providing conclusive evidence that fAβ1-42-stimulated NADPH oxidase activation in microglial cells is regulated by ATP released from microglia. Recently, it has been recognized that ATP can be released from LPS-stimulated microglial cells (Ferrari et al., 1997; Seo et al., 2004) , and a recent study reported that ATP release from glutamate-stimulated microglia was mediated by intracellular Ca 2+ release (Liu et al., 2006) . Our data show Ca 2+ influx from extracellular sources only, implying that fAβ1-42-stimulated ATP release from microglia occurs by a mechanism distinct from that involved in glutamate-stimulated ATP release. Future work on identifying the mechanisms involved in fAβ-stimulated ATP release from microglia will provide a better understanding of the role of microglia in pathological conditions of AD.
In conclusion, our study describes a novel mechanism of ROS production by microglia in AD by demonstrating that fAβ1-42 indirectly stimulates NADPH oxidase activation in microglia through ATP release and subsequent activation of P2X 7 R.
